GlycoMimetics, Inc. (NASDAQ:GLYC) Q2 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics, Q2 2023 Earnings Call. At this time all participants are in listen-only mode.

Related Keywords

Boston ,Massachusetts ,United States ,Dana Farber Cancer Institute ,Brian Hahn ,Christian Dinneen ,Harout Semerjian ,John Moran ,John Horan ,Glycomimetics Inc ,Nasdaq ,Data Monitoring Committee ,Company Counsel At Glycomimetics ,National Cancer Institute ,Call Transcript August ,Christian Dinneen Long ,Company Counsel ,Chief Executive Officer Brian Hahn ,Chief Financial Officer ,Edwin Rock ,Chief Medical ,Chief Medical Officer ,Boston Children ,Dana Farber Cancer ,Vaso Occlusive Crisis ,Boris Peaker ,Boris Your ,Roger Song ,Healthcare Conference ,